Pakistan joins 52 countries on Covid-19 research, development

Published August 27, 2021
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. —  AFP/File
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. — AFP/File

ISLAMABAD: Pakistan has enrolled to participate in the ‘Solidarity PLUS’ clinical trial led by the World Health Organisation (WHO) that will evaluate three potential drugs — artesunate, imatinib and infliximab — for the treatment of Covid-19 infections aiming to protect people from severe hospitalisation and death because of the pandemic.

WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study, making up the largest global collaboration on Covid-19 research and development.

The three potential drugs were selected by a panel of experts who assess all available evidence on relevant therapeutics. The drugs have proven effectiveness in treating other life-threatening diseases. Artesunate is used for severe malaria, imatinib for specific cancers, and infliximab for diseases of the immune system, such as Crohn’s disease and rheumatoid arthritis.

“Covid-19 has been the most disruptive public health challenge in the past century. In less than two years, the pandemic has claimed over 4.4 million lives across the world, overwhelmed health systems, and disrupted economies and societies.

“It is critical that we find effective treatments to prevent severe hospitalisation and death caused by Covid-19. We appreciate the efforts of countries in the region in collaborating on vital global studies for the treatment of Covid-19, in the spirit of solidarity,” said Dr Ahmed Al-Mandhari, WHO Regi­onal Director for the Eastern Mediterranean.

Published in Dawn, August 27th, 2021

Opinion

Editorial

Increased inflows
Updated 12 Jan, 2025

Increased inflows

Govt must devise a strategy to increase industrial and agricultural productivity to boost exports and reduce reliance on uncertain remittances.
Gwadar’s potential
12 Jan, 2025

Gwadar’s potential

THE Gwadar deep-sea port, completed in 2007, was supposed to be a shining success for the other newly built ports in...
Broken metropolis
12 Jan, 2025

Broken metropolis

KARACHI, Pakistan’s economic juggernaut, is the largest contributor to the nation’s tax revenue. The Federal...
Afghan outreach
Updated 11 Jan, 2025

Afghan outreach

Islamabad should stress stronger counterterrorism measures, yet also engage the Taliban high command in Kandahar as well as politicians in Kabul.
Fragile recovery
11 Jan, 2025

Fragile recovery

STATE Bank Governor Jameel Ahmed appears to be quite optimistic over recent economic gains. That is not unusual;...
Destination Europe
11 Jan, 2025

Destination Europe

THE country’s aviation authorities can rest a little easy. After a four-year banishment from European skies,...